Status:
TERMINATED
Chloroprocaine Spinal for Outpatient Knee Surgery
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Knee Arthroscopy
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Outpatient knee surgeries with duration of less than one hour pose a challenge to the use of spinal anesthesia given that traditional agents remain in effect for 2-3 hours, thus creating a mismatch be...
Eligibility Criteria
Inclusion
- Patients scheduled for a knee arthroscopy that is anticipated to be less than one hour
- Age 18 to 80 years
- Ability to follow study protocol
- English speaking
Exclusion
- Hepatic or renal insufficiency
- Younger than 18 years old and older than 80
- Allergy or intolerance to one of the study medications
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (taking opioids for longer than 3 months)
- Patients unable to undergo a spinal anesthetic or Laryngeal Mask Airway (LMA)/GA or patient refusal to spinal anesthesia or LMA/GA
Key Trial Info
Start Date :
June 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2021
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03365752
Start Date
June 24 2018
End Date
February 4 2021
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021